Triple negative breast cancers, as a subgroup, are associated with a poor prognosis. But different subtypes within triple negative disease are associated with different outcomes…
Related Articles
Impact Factor
Neoadjuvant trial design: time for a brave new world?
Cover Story
Emiel Rutgers: a surgeon for the genomic era
Impact Factor